Fortis Advisors’s Boston Scientific BSX Stock Holding History

Fortis Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-272	Closed	-$9K	–	189
2020 Q1	$9K	Buy	+272	New	+$10.6K	0.01%	265

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fortis Advisors's BSX Position: Q2 2020 in Review

Fortis Advisors sold out of Boston Scientific (BSX) in Q2 2020, closing a stake of 272 shares — an estimated $9K sold.

Fortis Advisors first reported a position in BSX in Q1 2020 and held it in 1 quarter. The position peaked at $9K in Q1 2020. 840 funds tracked by Wall St. Rank hold BSX as of Q2 2020.

Fortis Advisors reported no remaining Boston Scientific position as of Q2 2020 after selling out during the quarter.
Fortis Advisors sold 272 Boston Scientific shares in Q2 2020, an estimated $9K.
Fortis Advisors first reported a position in Boston Scientific in Q1 2020 and held it in 1 quarter.
Fortis Advisors's Boston Scientific position peaked at $9K in Q1 2020.
840 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2020.

Based on Fortis Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.